Patricia Sebastian-Leon,Francisco Jose Sanz,Pietro Molinaro,Antonio Pellicer,Patricia Diaz-Gimeno
{"title":"尽管使用了供体卵母细胞,高龄产妇仍与每年生殖成功率下降有关:一项回顾性研究。","authors":"Patricia Sebastian-Leon,Francisco Jose Sanz,Pietro Molinaro,Antonio Pellicer,Patricia Diaz-Gimeno","doi":"10.1016/j.fertnstert.2025.05.150","DOIUrl":null,"url":null,"abstract":"OBJECTIVE\r\nTo study if there is an increasing risk of poor reproductive outcomes associated with age in IVF patients using donor oocytes and when it becomes clinically relevant.\r\n\r\nDESIGN\r\nMulticenter, retrospective cohort study SUBJECTS: IVF patients ≥35 years at 19 private fertility clinics in Spain.\r\n\r\nEXPOSURE\r\nA single day 5 embryo from a donor oocyte (<35 years) transferred to the IVF patient undergoing a hormone replacement therapy, between February 2000 and September 2022.\r\n\r\nMAIN OUTCOME MEASURES\r\nLive birth, implantation failure, and pregnancy loss rates were analyzed using a continuous scale of women's ages to determine the gradual effect of age that is clinically relevant. The relative risks of pregnancy loss and implantation failure after 40 years of age were calculated adjusting for body mass index, IVF cycle parameters, and the embryo's developmental stage and euploidy.\r\n\r\nRESULTS\r\nAnalysis of 33,141 good-quality, single embryo transfers identified the maternal age where reproductive rates worsened as 39, 40 and 43 years for implantation failure, live birth, and pregnancy loss rates, respectively. Before live birth rates drastically decreased, there was no significant increment in the relative risk for negative outcomes (p-value>0.05). Nevertheless, after the age of 40, the relative risk of implantation failure increased by 4.2% per year (RR = 1.042, 95% CI: 1.028-1.056; p-value <0.0001) while that of pregnancy loss increased by 3.2% per year (RR = 1.032, 95% CI: 1.013-1.051; p-value = 0.0007).\r\n\r\nCONCLUSION\r\nChallenging traditional paradigms that embryo factors drive the detrimental effect of age on reproductive outcomes, this study reveals that uterine age may also play a significant role in age-related detrimental effects. Given that embryo factors were controlled for, these findings suggest that the worsening of reproductive outcomes associated to the effects of age in the uterus. In addition, this study design identified the specific age at which the live birth rate decreases, and implantation failure rate and pregnancy loss rate increases. Our results encourage further study of how uterine age annually impacts pregnancy rates and support the uterus becoming a potential target for antiaging therapies aiming to improve outcomes of assisted reproductive technologies.","PeriodicalId":12275,"journal":{"name":"Fertility and sterility","volume":"45 1","pages":""},"PeriodicalIF":6.6000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Advanced maternal age was associated with an annual decline in reproductive success despite use of donor oocytes: A retrospective study.\",\"authors\":\"Patricia Sebastian-Leon,Francisco Jose Sanz,Pietro Molinaro,Antonio Pellicer,Patricia Diaz-Gimeno\",\"doi\":\"10.1016/j.fertnstert.2025.05.150\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"OBJECTIVE\\r\\nTo study if there is an increasing risk of poor reproductive outcomes associated with age in IVF patients using donor oocytes and when it becomes clinically relevant.\\r\\n\\r\\nDESIGN\\r\\nMulticenter, retrospective cohort study SUBJECTS: IVF patients ≥35 years at 19 private fertility clinics in Spain.\\r\\n\\r\\nEXPOSURE\\r\\nA single day 5 embryo from a donor oocyte (<35 years) transferred to the IVF patient undergoing a hormone replacement therapy, between February 2000 and September 2022.\\r\\n\\r\\nMAIN OUTCOME MEASURES\\r\\nLive birth, implantation failure, and pregnancy loss rates were analyzed using a continuous scale of women's ages to determine the gradual effect of age that is clinically relevant. The relative risks of pregnancy loss and implantation failure after 40 years of age were calculated adjusting for body mass index, IVF cycle parameters, and the embryo's developmental stage and euploidy.\\r\\n\\r\\nRESULTS\\r\\nAnalysis of 33,141 good-quality, single embryo transfers identified the maternal age where reproductive rates worsened as 39, 40 and 43 years for implantation failure, live birth, and pregnancy loss rates, respectively. Before live birth rates drastically decreased, there was no significant increment in the relative risk for negative outcomes (p-value>0.05). Nevertheless, after the age of 40, the relative risk of implantation failure increased by 4.2% per year (RR = 1.042, 95% CI: 1.028-1.056; p-value <0.0001) while that of pregnancy loss increased by 3.2% per year (RR = 1.032, 95% CI: 1.013-1.051; p-value = 0.0007).\\r\\n\\r\\nCONCLUSION\\r\\nChallenging traditional paradigms that embryo factors drive the detrimental effect of age on reproductive outcomes, this study reveals that uterine age may also play a significant role in age-related detrimental effects. Given that embryo factors were controlled for, these findings suggest that the worsening of reproductive outcomes associated to the effects of age in the uterus. In addition, this study design identified the specific age at which the live birth rate decreases, and implantation failure rate and pregnancy loss rate increases. Our results encourage further study of how uterine age annually impacts pregnancy rates and support the uterus becoming a potential target for antiaging therapies aiming to improve outcomes of assisted reproductive technologies.\",\"PeriodicalId\":12275,\"journal\":{\"name\":\"Fertility and sterility\",\"volume\":\"45 1\",\"pages\":\"\"},\"PeriodicalIF\":6.6000,\"publicationDate\":\"2025-05-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fertility and sterility\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.fertnstert.2025.05.150\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fertility and sterility","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.fertnstert.2025.05.150","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Advanced maternal age was associated with an annual decline in reproductive success despite use of donor oocytes: A retrospective study.
OBJECTIVE
To study if there is an increasing risk of poor reproductive outcomes associated with age in IVF patients using donor oocytes and when it becomes clinically relevant.
DESIGN
Multicenter, retrospective cohort study SUBJECTS: IVF patients ≥35 years at 19 private fertility clinics in Spain.
EXPOSURE
A single day 5 embryo from a donor oocyte (<35 years) transferred to the IVF patient undergoing a hormone replacement therapy, between February 2000 and September 2022.
MAIN OUTCOME MEASURES
Live birth, implantation failure, and pregnancy loss rates were analyzed using a continuous scale of women's ages to determine the gradual effect of age that is clinically relevant. The relative risks of pregnancy loss and implantation failure after 40 years of age were calculated adjusting for body mass index, IVF cycle parameters, and the embryo's developmental stage and euploidy.
RESULTS
Analysis of 33,141 good-quality, single embryo transfers identified the maternal age where reproductive rates worsened as 39, 40 and 43 years for implantation failure, live birth, and pregnancy loss rates, respectively. Before live birth rates drastically decreased, there was no significant increment in the relative risk for negative outcomes (p-value>0.05). Nevertheless, after the age of 40, the relative risk of implantation failure increased by 4.2% per year (RR = 1.042, 95% CI: 1.028-1.056; p-value <0.0001) while that of pregnancy loss increased by 3.2% per year (RR = 1.032, 95% CI: 1.013-1.051; p-value = 0.0007).
CONCLUSION
Challenging traditional paradigms that embryo factors drive the detrimental effect of age on reproductive outcomes, this study reveals that uterine age may also play a significant role in age-related detrimental effects. Given that embryo factors were controlled for, these findings suggest that the worsening of reproductive outcomes associated to the effects of age in the uterus. In addition, this study design identified the specific age at which the live birth rate decreases, and implantation failure rate and pregnancy loss rate increases. Our results encourage further study of how uterine age annually impacts pregnancy rates and support the uterus becoming a potential target for antiaging therapies aiming to improve outcomes of assisted reproductive technologies.
期刊介绍:
Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.